It is used to treat the patient subgroups body of amyotrophic lateral sclerosis using masitinib

• 收藏
• 分享

专利权人:

에이비 사이언스

发明人:

마우지 알랭,키넷 진-피에르,맨스필드 콜린

申请号：

KR1020187026871

公开号：

KR1020180125966A

申请日:

2017.03.24

申请国别(地区):

KR

年份:

2018

代理人:

摘要：

Whose start before treatment the present invention relates to a kind of for treating variation amendment amyotrophic lateral sclerosis Evaluation of Functional scale (alsfrs r) with not aggressive or medium pushing amyotrophic lateral sclerosis (ALS) change rate, monthly < 1.1 point, the method include give tyrosine kinase inhibitor or mast cell inhibitor, especially masitinib or its pharmaceutically acceptable salt or solvate, optionally at least one active pharmaceutical ingredient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/